March 02, 2023 | 10:41
After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.
February 23, 2023 | 14:00
With the Ministry of Health’s latest pledge to improve upon medical legislation, international businesses continue to pin high hopes on marketing authorisation regulations for medical devices and distribution rights in order to drive their plans forward.
December 16, 2022 | 11:40
Merger and acquisition moves are one of the more effective measures for foreign investors entering the Vietnamese medical and pharmaceutical industry, utilising available factories and inexpensive labour. Ngo Thanh Hai, Nguyen Dieu Quynh, and Le Anh Thu from LNT & Partners offers an overview of the factors and barriers involved when it comes to dealmaking in pharma.
December 07, 2022 | 14:00
More international pharma and medical device businesses are rushing to venture further in Vietnam, anticipating wide growth potential.
December 01, 2022 | 13:00
Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
August 20, 2022 | 14:00
Pharma violations involving domestic and foreign-invested enterprises are still on the rise, despite stricter rules being introduced by Vietnamese healthcare authorities
August 10, 2022 | 14:00
International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
August 02, 2022 | 08:00
After a significant decrease in the value of mergers and acquisitions (M&As) in Vietnam in 2018-2020, such activities have recovered in the past year. Ngo Thanh Hai and Nguyen Dieu Quynh from LNT & Partners offer their insight into the current M&A trend in the local pharmaceutical market.
July 29, 2022 | 10:00
Vietnam’s pharma giants are growing with new strategies from foreign leadership, easing local doubts over the possible disappearance of local strong brands.
March 01, 2022 | 19:00
While Vietnam’s pharmaceutical and healthcare industries are waiting for a big push to shine, with potential trends to focus on import and production of vaccines and tech transfer, foreign enterprises continue to seek more adjustments of legal barriers.
February 18, 2022 | 14:00
A decade of innovation is in sight for Vietnam’s largest pharmaceutical companies, as long as quick adaption and changes in business strategy are carried out.
December 12, 2021 | 08:00
With strong commitments and efforts to reduce greenhouse gas emissions globally, AstraZeneca is pioneering the Net-Zero Corporate Standard of the new Science Based Targets initiative in the pharmaceutical industry. Nitin Kapoor, chairman and general director of AstraZeneca Vietnam, discussed with Thuy Nguyen the company’s sustainable development strategy and its contribution to the sustainable growth of healthcare in Vietnam.
November 25, 2021 | 12:13
Pharmaceutical companies like Pfizer, Novartis, Roche, and GSK performed well in the first three quarters of 2021, with plans to venture further into the lucrative Vietnamese market.
November 19, 2021 | 08:00
Together with vaccines, multinational corporations are on the journey to make oral antiviral medication for the treatment of COVID-19, expecting to bring new innovation for infections and promising profitable years for pharma giants.
August 26, 2021 | 10:00
Despite having limited facilities for life sciences real estate, Vietnam could open up to potential development in the industry, analysts say.